论文部分内容阅读
本文报道联合应用顺铀和重组人白细胞介素Ⅱ（rlL—Ⅱ）胸腔内注射治疗17例恶性肿瘤合并恶性胸水的疗效。17例患者中肺癌7例，乳腺癌6例，结肠癌、卵巢癌各2例。结果近期效果满意。总有效率（CR＋PR）82．4％（14／17），其中完全缓解（CR）6例，部分缓解（PR）8例。顺铂与rlL—Ⅱ联合应用表现出明显的协同作用。
This article reported the combined use of uranyl and recombinant human interleukin II (rlL-II) intrapleural injection for the treatment of malignant tumors with malignant pleural effusion. Among the 17 patients, 7 were lung cancer, 6 breast cancer, 2 colon cancer and 2 ovarian cancer. The results were satisfactory in the near future. The total effective rate (CR+PR) was 82.4% (14/17), including 6 cases of complete remission (CR) and 8 cases of partial remission (PR). The combined use of cisplatin and rlL-II showed a clear synergistic effect.